A r t i c l e s discrete groups of genes and proteins have been causally linked with specific ciliopathies, single-locus allelism has been insufficient to explain the variable penetrance and expressivity of such disorders, leading to the suggestion that genetic variation across multiple sites of the ciliary proteome influences clinical outcome. Consistent with this notion, mutations in NPHP1, INVS (also called NPHP2), NPHP3 and NPHP4 have been shown to exacerbate extra-renal phenotypes in individuals with nephronophthisis (NPHP) who have primary lesions at one of the other NPHP genes 3 , whereas mutations in some of the genes that cause Meckel-Gruber syndrome (MKS) can also contribute mutations in individuals diagnosed with NPHP 4,5 , Joubert syndrome (JBTS) [6] [7] [8] [9] [10] [11] [12] [13] or Bardet-Biedl syndrome (BBS) 14 . Recently, mutations in RPGRIP1L, loss of function of which causes MKS and JBTS, have been shown to modify the penetrance of retinal degeneration across multiple ciliopathies 15 , whereas an allele in AHI1 can modify retinal phenotypes in individuals with NPHP 16 .
These observations have raised two possibilities. First, if the model outlined above is correct, one would predict that some genes critical to ciliary function would contribute alleles that will appear (genetically) to be necessary and sufficient to cause discrete ciliopathy phenotypes in humans. Second, the same loci should contribute modifier alleles across the same phenotypic spectrum, some of which would be expected to contribute to the severity and/or pleiotropy of the disease.
To test these hypotheses, we initiated a systematic screening of all genes known to be necessary for ciliary biogenesis and function coupled with functional assessment of the variants detected (irrespective of their genetically derived pathogenic potential under a strict Mendelian model). We chose to test this model on TTC21B for several reasons. First, it encodes a bona fide axonemal protein that is required for retrograde intraflagellar transport 17 . Second, homozygous null mutations in this gene are responsible for the embryonic lethal alien phenotype in the mouse, a mutant whose anatomical features overlap with some of the severe ciliopathies in humans 18 . Third, TTC21B contains several tetratricopeptide (TPR) domains that seem important for ciliary function by virtue of their enrichment in the ciliary proteome and photoreceptor sensory cilium proteome 19, 20 and their presence in numerous human ciliopathy-associated proteins such as BBS4 (ref. 21 ) and BBS8 (ref. 22) .
RESULTS

Resequencing of TTC21B in ciliopathy cases and controls
To comprehensively assess the potential contribution of TTC21B to human ciliopathies, we sequenced all 29 coding exons of TTC21B in a clinically diverse cohort of 753 cases without preselection for known ciliopathy gene mutations or genetic linkage data. The cohort spanned the clinical severity spectrum and included individuals with NPHP (with and without extra-renal phenotypes), JBTS, BBS, JATD and MKS ( Supplementary Table 1 ). In parallel, to assess the extent of coding variation at this locus, we also sequenced 398 unaffected individuals ( Supplementary Table 1 ). We identified 48 distinct, previously unreported variants affecting the TTC21B coding sequence, including 2 frameshifts and 2 nonsense, 4 splice junction and 40 missense variants. Most variants were present in the heterozygous state, and their rarity necessitated functional characterization so that their genetic contribution to ciliopathies could be modeled in detail. We therefore proceeded to functionally evaluate all missense variants in TTC21B, including all nonsynonymous alleles present in SNP databases ( Supplementary Table 2 ).
In vivo complementation assays
We showed previously that in vivo rescue of zebrafish ciliary phenotypes with wildtype or mutant human mRNAs represents a robust, physiologically relevant tool to assay allele pathogenicity 14, 15, 23 . After reciprocal BLAST, we identified a single ortholog of TTC21B in the zebrafish genome (having 68% identity and 84% similarity), and we were able to detect an endogenous ttc21b message by RT-PCR as early as the embryonic shield stage (data not shown). Next, we designed a translation-blocking morpholino (tb-MO) targeting ttc21b, which we injected into two-cell-stage embryos (n = 50-100 per injection dose; injection doses of 2 ng, 4 ng, 6 ng, 8 ng or 10 ng). Masked scoring of live embryos at the eight-to-nine somite stage reproduced A r t i c l e s previously reported gastrulation phenotypes in a dose-dependent manner (Supplementary Fig. 1 ). These defects included shortening of the embryonic axis, widening and kinking of the notochord and broadening and thinning of the somites, each of which enabled grouping into phenotypic classes according to previously described objective phenotypic criteria 14 (normal, class I and class II; Fig. 1a,b ). Importantly, we were able to rescue morphant phenotypes, with co-injection of wildtype human TTC21B mRNA producing significant improvement (P < 0.0001; wildtype rescue versus MO) ( Fig. 1b and Supplementary Table 3 ). Finally, to ensure the specificity of the ttc21b tb-MO, we repeated the in vivo rescue assay with a ttc21b splice-blocking MO (sb-MO), which reduced wildtype ttc21b by >80%. We observed dose-dependent gastrulation phenotypes similar to the tb-MO ( Supplementary Fig. 1 ), which could also be rescued with a similar efficiency as the tb-MO (data not shown).
We subsequently tested each of the 40 newly discovered, nonsynonymous TTC21B variants using an in vivo rescue assay. Injection cocktails containing tb-MO and each mutant TTC21B message were injected into zebrafish embryos (n = 71-180 embryos per injection, using masked scoring) and compared to the rescue efficiency of wildtype rescue or tb-MO alone ( Fig. 1b and Supplementary  Table 3 ). Using this approach, we observed that, first, nearly half of TTC21B variants (n = 18 out of 40) were significantly worse than wildtype rescue but were significantly better than tb-MO alone (P < 0.05 for each comparison), indicating they were likely hypomorphic alleles. We also observed functionally null alleles (n = 11; not significantly improved from tb-MO alone). The remaining alleles were scored as benign (n = 11; not significantly exacerbated in comparison to wildtype rescue), which was consistent with our genetic prediction, as 3 out of 11 alleles were detected in similar frequencies in cases and controls and 8 out of 11 alleles were detected exclusively in controls. We also tested four SNPs from HapMap encoding nonsynonymous TTC21B changes (rs1432273, rs7592429, rs16851307 and rs2163649) and found each to be benign, increasing our confidence in the specificity of the assay (Supplementary Tables 2 and 3) . Finally, to eliminate the possibility of mutant mRNA toxicity as the supplementary table 6 for measurement data). (c) Protein stability defects for some TTC21B missense variants. Compared to wildtype, p.Pro209Leu and p.Arg411Gly result in diminished levels of TTC21B; we did not detect the p.Ile1208Ser protein (see supplementary table 7 for densitometry data). Na + /K + -ATPase was used as a loading control. NT, not transfected. (d) Transiently transfected pCAG-V5-TTC21B-IRES-EGFP constructs express at similar levels in mIMCD3 cells. RT-PCR data are shown for human TTC21B amplified from complementary DNA (cDNA) generated from total RNA extracted from mIMCD3 cells 72 h post transfection. Murine β-actin was used as a loading control.
A r t i c l e s primary cause for gastrulation defects, we injected each of the 40 transcripts in the absence of tb-MO and found each to be similar to wildtype mRNA alone (χ 2 for each comparison was not significant; Supplementary Table 4 ).
To further assess pathogenicity of TTC21B variants, we measured anatomical features labeled in situ with a cocktail of pax2, krox20 and myoD riboprobes on whole-embryo flat mounts. We have shown previously that the ratio of two-dimensional embryo measurements spanning the distal ends of the fifth appreciable somites (w) versus the length of the notochord as indicated by adaxial cell labeling (l) is an effective approach to quantify gastrulation defects in ciliary morphants 15 . We randomly chose a subset of 15 different mutant rescue injected batches, age matched at 9-10 somites, and calculated the w/l ratio for each embryo (n = 7-10 embryos per injection). Upon comparison of mutant rescue versus wildtype w/l ratios (once again, scored masked to injection cocktail), we observed that 14 out of 15 were in agreement with the in vivo scores ( Fig. 1c and d and Supplementary Tables 2 and 5).
In vitro complementation assays
To further validate the zebrafish assays, we turned next to an in vitro mammalian cell model. Endogenous Ttc21b localizes to the basal body and the ciliary axoneme in ciliated murine inner medullary collecting duct (mIMCD3) cells 18 , an observation which we reproduced with transient transfection of an expression vector harboring the fulllength wildtype TTC21B open reading frame (ORF; Supplementary  Figs. 2 and 3) . Furthermore, mIMCD3 cells stably transfected with Ttc21b short hairpin RNA (shRNA) (resulting in 87.5% suppression of Ttc21b) display shortened cilia in comparison to wildtype cells 18 . We subsequently used these cell lines to test allele pathogenicity based on the ability of transiently transfected mutant constructs to rescue defects in cilia length (n = 85-155 cilia measured per construct). Whereas wildtype TTC21B resulted in the full rescue of cilia length in transiently transfected cells (P = 0.94 compared to an mIMCD3empty vector), transient expression of 17 different mutant proteins (the same group examined in the zebrafish morphometric assay, in addition to p.Leu1002Val and p.Asp1041Asn) indicated that four variants were indistinguishable from mIMCD3-Ttc21b shRNA cells alone (p.Met280Val, p.Pro753Leu, p.Arg939Trp and p.Ile1208Ser), suggesting that they are functional nulls in this assay. The other 13 variants resulted in partial but not complete rescue of cilia length, indicating that they are hypomorphic alleles ( Fig. 2a,b and Supplementary Tables 2 and 6). Importantly, these results are fully concordant with our in vivo zebrafish scoring results. These observations are likely due to cellular mislocalization (which were abnormal for 15 out of 16 variants tested; Supplementary Table 2 and Supplementary Fig. 3 ) and/ or aberrant protein levels (as determined by protein blot) (Fig. 2c,d and Supplementary Tables 2 and 7) . The p.Leu795Pro mutant protein was the only variant that was expressed at normal levels and localized correctly to the basal body, suggesting that its effect probably lies in the biochemical function of TTC21B.
TTC21B in the mammalian photoreceptor
Finally, we investigated the potential contribution of TTC21B sequence variants in discrete endophenotypes of physiological relevance to our ciliopathy cohort. The alien mouse exhibits axial skeleton defects, polydactyly and failure of neural tube closure, all of which mirror hallmark features in individuals with JATD and MKS in our study 24 . However, neonatal lethality by embryonic day 18.5 precluded us from studying the effects of Ttc21b suppression in postnatal onset phenotypes such as retinal degeneration. As part of our ongoing studies of proteins in the mouse photoreceptor sensory cilium 20 , we investigated the function of Ttc21b in mammalian photoreceptors in a rodent model. First, we developed an antibody against murine Ttc21b and showed that it localizes specifically to the transition zone of the mouse photoreceptor sensory cilia, as evidenced by localization just proximal to endogenous murine retinitis pigmentosa 1 (Rp1), which is located in the outer segment portion of the photoreceptor sensory cilia axoneme 25 (Supplementary Fig. 2c) . Next, to test the effects of Ttc21b suppression in the retina, we generated a rodentspecific shRNA vector targeting the Ttc21b transcript (shRNA-Ttc21b (2923)). Through in vivo electroporation of shRNA-Ttc21b (2923) in neonatal rat retinas, we observed significantly shortened (P < 0.0001), abnormally shaped photoreceptor sensory cilia, a specific defect which could be rescued with co-injection of a human A r t i c l e s TTC21B expression vector, suggesting that Ttc21b is required for normal photoreceptor development (Supplementary Fig. 4) .
As a further means to probe the pathogenicity of TTC21B variants found in our cohort, we used the in vivo retinal electroporation approach to assess mutant protein localization in rat photoreceptor sensory cilia. We randomly selected six different nucleotide changes identified in cases and expressed them transiently in rat photoreceptors. Similar to the zebrafish studies, the p.Pro209Leu, p.Arg411Gly, p.Leu1002Val, p.Thr1103Arg and p.Asp1041Asn mutant proteins mislocalized partially in the photoreceptor, consistent with the notion that they are hypomorphic alleles in vivo ( Fig. 3 and Supplementary  Table 2 ) and partially rescue the ciliary length phenotypes in vitro. By contrast, the p.Ile1208Ser protein is undetectable in transfected photoreceptor cells, which recapitulates both the in vitro protein analyses and completely fails to rescue ciliary length in vitro, suggesting it is functionally null, probably from loss of protein stability or increased degradation (Figs. 2 and 3 and Supplementary Tables 2 and 7) .
Mutations in TTC21B cause JATD and isolated NPHP
With functional data to inform the pathogenicity of each TTC21B allele detected in our cohorts, we first asked whether variants at that locus were sufficient to explain the clinical phenotypes in families with ciliopathies. In six pedigrees, we detected two pathogenic mutations that segregated under an autosomal recessive model (Fig. 4a) . Representing the severe ciliopathies, JATD family 3 carried a heterozygous nonsense mutation and a heterozygous nonsynonymous mutation encoding a highly conserved p.Leu795Pro change shown be hypomorphic by in vivo testing ( Fig. 4a and Supplementary Tables 2  and 8) , which was neither seen in 796 control chromosomes sequenced for the whole of TTC21B nor found in an additional 440 ethnically matched control chromosomes genotyped specifically for this allele ( Table 1) . Additionally, the members of three families with early onset NPHP with extra-renal phenotypes were all compound heterozygotes, having a pathogenic missense variant and either a splice junction variant or a truncating allele. Two families harbored a hypomorphic A r t i c l e s p.Pro209Leu-encoding allele (as determined by all six lines of functional evidence; Supplementary Table 2 ) combined with either a nonsense mutation (F244) or a splice junction variant predicted to result in deletion of a partial TPR domain (A34), with each variant absent from the matched controls. Additionally, family F514 (ref. 26 ) carried a heterozygous p.Trp150Arg change shown to be functionally null in the in vivo zebrafish rescue assay and a splice variant predicted to result in a 54-amino-acid deletion (Fig. 4a , Table 1 A r t i c l e s and Supplementary Table 2 ). Causative TTC21B lesions were also implicated in clinically milder ciliopathies: two consanguineous kindreds (F623 and A3214) with isolated NPHP each harbored the same p.Pro209Leu homozygous mutation ( Fig. 4 and Table 1 ). Of note, the Leu209-encoding variant is a likely founder allele, as we observed the same haplotype at the coding regions spanning the locus in all p.Pro209Leu homozygotes (Supplementary Table 9 ).
Enrichment of pathogenic TTC21B changes in ciliopathies
Because an additional 38 unrelated cases (5%) harbored heterozygous TTC21B changes that were detrimental to protein function ( Table 1) , we wondered if there was a specific enrichment for such TTC21B lesions in ciliary disease. First, we returned to our medical resequencing data and, to exclude bias due to differences in ethnicity or consanguinity, we analyzed only the cases and controls of northern European descent. Among cases and controls (n = 1,110 and 610 chromosomes (chromosomes from 440 controls plus an additional 85 individuals from HapMap), respectively; Supplementary Table 1 ), we noted no significant difference in the frequency of newly discovered nucleotide changes per chromosome analyzed in the coding regions of TTC21B (cases = 3.4% (38 out of 1,110), controls = 2.0% (12 out of 610), P = 0.06; Supplementary  Table 2 ). However, upon consideration of pathogenic changes only, we observed a significant enrichment of pathogenic variants in northern European cases versus controls (cases = 2.5% (28 out of 1,110), controls = 0.06% (4 out of 610), P = 0.003; Supplementary  Table 2 ); we reproduced this result upon permutation analysis, in which genotypes were assigned randomly without replacement in the two cohorts, as reported previously 15 .
Genetic interaction of TTC21B with other ciliopathy loci
Taken together, we found likely pathogenic alleles in ~5% of ciliopathy cases, suggesting that TTC21B might be a common contributor to the total mutational load in ciliopathies, not least because over one-third of cases with heterozygous TTC21B alleles harbor causal trans alleles in 13 known causal ciliopathy genes ( Table 1) . To test this concept, we asked whether injection of a subeffective dose of ttc21b tb-MO would alter the severity or expressivity of mid-somitic phenotypes caused by the suppression of each of the 13 endogenous ciliopathy transcripts. Consistent with our genetic predictions, gastrulation phenotypes were markedly exacerbated in the presence of a subeffective dose of ttc21b tb-MO compared to a single injection of either ttc21b tb-MO or ciliopathy gene MO alone for 13 out of 13 double injections ( Fig. 5) . Importantly, the distinct effects on phenotypic severity observed across co-injections likely reflect the specificity of each ttc21b trans interaction; some pairwise combinations gave a reproducible (n = 3 injections, 50-75 embryos per injection, scored blind) marked increase in the overall percentage of affected embryos (for example, bbs1 and ttc21b), whereas other combinations increased the percentage of severely affected embryos (for example, bbs4 and ttc21b; Fig. 5 ).
DISCUSSION
Genetic lesions affecting the function of ciliary and basal body proteins are beginning to offer the opportunity to model an important genetic paradigm. Cumulative phenotypic and genotypic data from the ~30 known causal ciliopathy loci in clinically diverse cohorts have indicated the presence of numerous pathogenic mutations that can both drive recessive phenotypes and contribute likely second-site modifiers. This model offers an opportunity to improve the predictive power of genotypic information, as a functionally derived annotation of the total mutational load of the ciliopathy module might improve genotype-phenotype correlations. The identification of causal and modifier mutations in TTC21B supports this model. Importantly, this is the first locus for which systematic ciliopathy resequencing was undertaken in the absence of prior genetic data linking this locus to a human disorder. The rarity of the discovered alleles, almost all of which are private mutations, coupled to the phenotypic variability of our affected cohorts, precludes, at present, the association of specific alleles with discrete ciliopathy endophenotypes. Comparison of mouse and human data provide some limited insights, in that homozygous null Ttc21b is embryonic lethal in mice and the same genotype is unlikely to be found in affected humans, yet a hypomorphic allele coupled to a null mutation appears sufficient to cause JATD. However, a similar genotype (c.2758-2A>G het; p.Pro209Leu het or p.Cys552X het; p.Pro209Leu het) leads to early onset NPHP, whereas p.Pro209Leu homozygosity leads to apparently isolated NPHP. Interestingly, the same p.Pro209Leu allele was also found in the heterozygous state in an individual BBS with cystic renal disease (prevalence in BBS <24%) 27 , leading us to speculate that the presence of this mutation might contribute to the development of renal phenotypes. It is also interesting to note that, for five of the alleles tested in the zebrafish gastrulation system, injection of mutant mRNA exacerbated the MO phenotype. Although this might suggest that these alleles act as dominant negatives, injection of increased amounts of mutant mRNA alone did not induce any phenotypes in wildtype embryos (data not shown). This raises the possibility that these alleles might exert a toxic effect only when the levels of wildtype protein fall below a critical threshold. A better appreciation of the biochemical properties of wildtype and mutant TTC21B will be required to understand this mechanism.
Given recent advances in sequencing technology, these data not only encourage efforts to conduct saturated resequencing of the ciliary proteome 28 but also to implement a similar approach to other definable functional modules of the morbid human genome. However, we note that without functional annotation, sequencing alone might Normal Class I Class II Figure 5 In vivo modeling of TTC21B genetic interaction with other ciliopathy loci. Zebrafish ttc21b interacts genetically with all loci known to contribute to disease in our ciliopathy cohort, including bbs1, bbs2, bbs4, bbs6, bbs7, bbs10, bbs12, tmem216, nphp4, cc2d2a, rpgrip1l, mks1 and cep290 (table 1). Co-injection of a subeffective dose of ttc21b morpholino with any other single ciliopathy morpholino markedly exacerbates either the overall penetrance of gastrulation phenotypes (in comparison to the same doses injected alone) or a specific severity class.
not always be sufficient to provide appropriate resolution. As such, efforts to develop functional assessment of the biochemical and/or cellular output of discrete modules should be integral parts of individual exome and genome resequencing.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Accession codes. The data from this study are deposited in GenBank under the following accession codes: Homo sapiens TTC21B mRNA, NM_024753; Homo sapiens TTC21B amino acid, NP_079029; and Danio rerio ttc21b mRNA, NM_001128258.
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